ZA200601991B - Process for the preparation of renzapride and intermediates thereof - Google Patents

Process for the preparation of renzapride and intermediates thereof

Info

Publication number: ZA200601991B
Authority: ZA; South Africa
Prior art keywords: renzapride; intermediates; preparation
Prior art date: 2003-09-09

Application number

ZA200601991A

Other languages

English (en)

Inventor

Palmer Richard Michael John

Knight John

Meyers Nicholas Leslie

Original Assignee

Alizyme Therapeutics Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-09

Filing date

2006-03-08

Publication date

2009-08-26

2006-03-08 Application filed by Alizyme Therapeutics Ltd filed Critical Alizyme Therapeutics Ltd

2009-08-26 Publication of ZA200601991B publication Critical patent/ZA200601991B/xx

Links

239000000543 intermediate Substances 0.000 title 1
GZSKEXSLDPEFPT-IINYFYTJSA-N renzapride Chemical compound COC1=CC(N)=C(Cl)C=C1C(=O)N[C@H]1[C@H](C2)CCC[N@]2CC1 GZSKEXSLDPEFPT-IINYFYTJSA-N 0.000 title 1
229950003039 renzapride Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)

ZA200601991A 2003-09-09 2006-03-08 Process for the preparation of renzapride and intermediates thereof ZA200601991B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0321091.1A GB0321091D0 (en)	2003-09-09	2003-09-09	Synthesis

Publications (1)

Publication Number	Publication Date
ZA200601991B true ZA200601991B (en)	2009-08-26

Family

ID=29226752

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200601991A ZA200601991B (en)	2003-09-09	2006-03-08	Process for the preparation of renzapride and intermediates thereof

Country Status (17)

Country	Link
US (2)	US7189852B2 (fr)
EP (1)	EP1664048A2 (fr)
JP (1)	JP2007505089A (fr)
KR (1)	KR20060092211A (fr)
CN (1)	CN1849320A (fr)
AR (1)	AR045625A1 (fr)
AU (1)	AU2004270465A1 (fr)
BR (1)	BRPI0414200A (fr)
CA (1)	CA2537536A1 (fr)
EA (1)	EA200600563A1 (fr)
GB (1)	GB0321091D0 (fr)
IL (1)	IL173736A0 (fr)
MX (1)	MXPA06002743A (fr)
NO (1)	NO20061575L (fr)
TW (1)	TW200526661A (fr)
WO (1)	WO2005023808A2 (fr)
ZA (1)	ZA200601991B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080008933A1 (en) *	2005-12-23	2008-01-10	Boston-Power, Inc.	Lithium-ion secondary battery
US7811707B2 (en) *	2004-12-28	2010-10-12	Boston-Power, Inc.	Lithium-ion secondary battery
TWI426678B (zh) *	2006-06-28	2014-02-11	波士頓電力公司	具有多重充電率之電子裝置、電池組、充電於電子裝置中的鋰離子電荷儲存電源供應器之方法及可攜式電腦
US20090297937A1 (en) *	2008-04-24	2009-12-03	Lampe-Onnerud Christina M	Lithium-ion secondary battery
WO2010030875A1 (fr) *	2008-09-12	2010-03-18	Boston-Power, Inc.	Procédé et appareil pour éléments de batterie intégrés et gestion thermique
US20100289457A1 (en) *	2009-05-18	2010-11-18	Boston-Power, Inc.	Energy efficient and fast charge modes of a rechargeable battery
CN102481858B (zh) *	2009-09-01	2014-11-05	波士顿电力公司	大型电动载具的电池系统的安全和效能优化控制
JP2013504145A (ja) *	2009-09-01	2013-02-04	ボストン−パワー，インコーポレイテッド	大規模蓄電池システムおよび組み立て方法
BR112020001284B1 (pt)	2017-07-21	2023-05-09	Rohm And Haas Company	Composição de resina de poli(metacrilato de metila), e, artigo de fabricação compreendendo uma composição de resina de poli(metacrilato de metila)
US20220298107A1 (en) *	2019-08-29	2022-09-22	Janssen Biotech, Inc.	Substituted urea dihydroorotate dehydrogenase inhibitors
CN112094239A (zh) *	2020-11-03	2020-12-18	燃点(南京)生物医药科技有限公司	一种乌拉地尔杂质化合物、制备方法及其应用
CN113773219B (zh) *	2021-09-30	2024-08-13	内蒙古康普药业有限公司	一种甲氧氯普胺双氯杂质的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2119724B2 (de)	1970-04-24	1976-04-29	Teikoku Hormone Manufacturing Co. Ltd., Tokio	Verfahren zur herstellung einer halogensubstituierten benzoesaeure
JPS5010573B1 (fr) *	1970-04-24	1975-04-22
IE56226B1 (en)	1982-04-14	1991-05-22	Beecham Group Plc	Substituted azabicyclo compounds,process for their preparation and pharmaceutical compositions containing them
ZA832549B (en) *	1982-04-14	1988-09-28	Beecham Group Plc	Pharmaceutically active compounds
GB8523211D0 (en)	1985-09-19	1985-10-23	Beecham Group Plc	Compounds
GB8607163D0 (en) *	1986-03-22	1986-04-30	Beecham Group Plc	Chemical compound
US5330982A (en) *	1986-12-17	1994-07-19	Glaxo Group Limited	Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
US5140023A (en)	1990-04-27	1992-08-18	G. D. Searle & Co.	Azatetracycle compounds
MX9603998A (es)	1994-03-11	1997-12-31	Yamanouchi Pharma Co Ltd	Agonista receptor de 5-ht3, derivado de tiazol novedoso e intermediario del mismo.
GB0329319D0 (en) *	2003-12-18	2004-01-21	Alizyme Therapeutics Ltd	Synthesis

2003
- 2003-09-09 GB GBGB0321091.1A patent/GB0321091D0/en not_active Ceased
2004
- 2004-07-02 US US10/884,842 patent/US7189852B2/en not_active Expired - Lifetime
- 2004-09-02 TW TW093126521A patent/TW200526661A/zh unknown
- 2004-09-06 EA EA200600563A patent/EA200600563A1/ru unknown
- 2004-09-06 MX MXPA06002743A patent/MXPA06002743A/es unknown
- 2004-09-06 BR BRPI0414200-4A patent/BRPI0414200A/pt not_active IP Right Cessation
- 2004-09-06 CN CNA2004800259716A patent/CN1849320A/zh active Pending
- 2004-09-06 JP JP2006525881A patent/JP2007505089A/ja active Pending
- 2004-09-06 WO PCT/GB2004/003820 patent/WO2005023808A2/fr not_active Ceased
- 2004-09-06 KR KR1020067004708A patent/KR20060092211A/ko not_active Withdrawn
- 2004-09-06 AU AU2004270465A patent/AU2004270465A1/en not_active Abandoned
- 2004-09-06 CA CA002537536A patent/CA2537536A1/fr not_active Abandoned
- 2004-09-06 EP EP04768367A patent/EP1664048A2/fr not_active Withdrawn
- 2004-09-09 AR ARP040103240A patent/AR045625A1/es not_active Application Discontinuation
2006
- 2006-02-14 IL IL173736A patent/IL173736A0/en unknown
- 2006-03-08 ZA ZA200601991A patent/ZA200601991B/xx unknown
- 2006-04-07 NO NO20061575A patent/NO20061575L/no not_active Application Discontinuation
2007
- 2007-01-08 US US11/650,740 patent/US20070135641A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BRPI0414200A (pt)	2006-10-31
US20070135641A1 (en)	2007-06-14
MXPA06002743A (es)	2006-06-05
JP2007505089A (ja)	2007-03-08
EP1664048A2 (fr)	2006-06-07
GB0321091D0 (en)	2003-10-08
AU2004270465A1 (en)	2005-03-17
WO2005023808A2 (fr)	2005-03-17
NO20061575L (no)	2006-06-09
IL173736A0 (en)	2006-07-05
AR045625A1 (es)	2005-11-02
KR20060092211A (ko)	2006-08-22
CN1849320A (zh)	2006-10-18
EA200600563A1 (ru)	2006-12-29
TW200526661A (en)	2005-08-16
US20050049416A1 (en)	2005-03-03
US7189852B2 (en)	2007-03-13
CA2537536A1 (fr)	2005-03-17
WO2005023808A3 (fr)	2005-07-07

Publication	Publication Date	Title
IL173456A0 (en)	2006-06-11	Process for the preparation of 4-amino-3-quinolinecarbonitriles
IL164851A0 (en)	2005-12-18	Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
HUP0500851A3 (en)	2008-02-28	Process for the preparation of rosuvastatin
IL169648A0 (en)	2009-02-11	Novel structures and method of preparation
TWI339662B (en)	2011-04-01	Arylvinylazacycloalkane compounds and methods of preparation and use thereof
IL173736A0 (en)	2006-07-05	Process for the preparation of renzapride and intermediates thereof
AU2003271037A1 (en)	2005-04-14	The extractive of aweto and process for its preparation and uses
TWI347945B (en)	2011-09-01	Process for the preparation of thiazolopyrimidines
IL171789A (en)	2010-11-30	Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin
IL175156A0 (en)	2006-09-05	Process for the preparation of gabapentin
PL371583A1 (en)	2005-06-27	Process for the preparation of 7alpha-methylsteroids
GB0304555D0 (en)	2003-04-02	Compounds and methods of manufacture
IL173887A0 (en)	2006-07-05	A process for the preparation of cilostazol and of the intermediates thereof
SG111997A1 (en)	2005-06-29	Improved process for the preparation of polyalkylphenoxyaminoalkanes
AU2003298725A8 (en)	2004-06-23	Preparation of metallotexaphyrins
IL164788A0 (en)	2005-12-18	Process for the preparation of 3-isochromanone
SI1622926T1 (sl)	2009-12-31	Nov postopek in intermediati za pripravo 17-halogen-19-nor-steroidnih spojin
IL161897A0 (en)	2005-11-20	Process for the preparation of cephalexin
HK1092802A (en)	2007-02-16	Process for the preparation of renzapride and intermediates thereof
AU2003259544A1 (en)	2004-12-03	Process for the preparation of gabapentin
LT1641933T (lt)	2018-04-10	Cefradino gamybos būdas
ZA200509495B (en)	2009-03-25	Process for the preparation of nicotinaldehydes
EP1642964A4 (fr)	2007-04-25	Micro-organisme et procede pour la preparation de pravastatine
EP1386911A3 (fr)	2004-09-22	Procédé pour la préparation de sulfonates d'acyloxybenzene
HU0300255D0 (en)	2003-04-28	Process for the preparation of 2-phenyl-4-methyl-1-tosil-piperazine